Your search for major depressive disorder returned 387 results

In patients with migraine, structural and functional changes occur in brain regions that are not directly involved in processing pain signals.

A patient should be notified of the possibility of developing an ICD before initiating any dopaminergic treatment for PD, particularly dopamine agonists.

Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.

NMDA receptor signaling is increased in patients with depression and reduced in those with schizophrenia.

Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.

There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.

Comorbid psychological conditions affect cognitive function in Parkinson’s disease, and treatment can be complicated by overlapping symptoms.

Effectively treating pain may help improve cognitive and functional outcomes in patients with depression.

SPECT imaging can be more accurate in the diagnosis of traumatic brain injury and post-traumatic stress disorder than CT or MRI.

Migraine was more significantly associated with pain or muscle soreness than anxiety disorders in patients with depression.

A significant gender effect was observed in the cohort.

Time spent on mobile phones and social media may contribute to the rise in depression.

Pregnancy is a major risk factor for stroke in younger women, but not in older women.

Patients with type 2 diabetes and major depressive disorder spent a significant amount of time experiencing depressive episodes.

Those suffering from depression and those diagnosed with temporal lobe epilepsy present with dysfunction across several cognitive domains.

Acupuncture, neurostimulation, and other alternative treatments have been associated with up to a 50% reduction in headache days.

Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.

HIV-infected adults with major depressive disorder have a 30% increased risk for acute myocardial infarction.

Results indicate that patients with AUD show significant impairments in social problem resolution task.

New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.

A restricted number of surgical procedures are not associated with increased incidence of chronic opioid use.

Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.

The odd relationship may have more to do with the mental disorder than the drugs.

Sixty percent of patients responded to treatment.

The drug was found to work quickly in patients with clinical major depression.

Patients who continue to experience symptoms for a year or longer may not benefit from current therapies.

Depression of some degree is prevalent in a majority of patients with ALS.

Screening recommended for those aged 12 to 18, however there is insufficient evidence to assess for children aged 11 and younger.

When first-line therapies fail, physicians must consider several factors when choosing the next course of treatment for their RRMS patients.

While the optimal depression screening timing and interval remains unknown, the USPSTF suggests screening all adults, regardless of risk factors, who have not been screened previously.